Applies to doxapram: parenteral injection.

Side effects include:

Cough, dyspnea, tachypnea, headache, dizziness, apprehension, hypertension, flushing, sweating, nausea, vomiting, diarrhea, urinary retention, muscle spasticity.

For Healthcare Professionals

Applies to doxapram: intravenous solution.

General

-In preterm neonates and infants, this drug has caused significant QT interval prolongation (associated with atrioventricular block in some cases), bloody stools, abdominal distension, necrotizing enterocolitis, multiple gastric perforations/increased gastric residuals, neurodevelopmental delay, vomiting, premature teeth eruption, hypertension, irritability, jitteriness, hyperglycemia, glucosuria, erratic limb movements, excessive crying, and disturbed sleep.

-Seizures have occurred in premature neonates with risk factors such as a previous seizure, perinatal asphyxia, or intracerebral hemorrhage. In many cases, this drug was given following administration of xanthine derivatives (e.g., caffeine, aminophylline, or theophylline).^[Ref]

Cardiovascular

Frequency not reported: Phlebitis, heart rate variations, lowered T-waves, arrhythmia, ventricular tachycardia, sinus tachycardia, ventricular fibrillation, bradycardia, extrasystole, chest pain, chest tightness, increased blood pressure, flushing^[Ref]

Dermatologic

Frequency not reported: Pruritus, sweating^[Ref]

Gastrointestinal

Frequency not reported: Nausea, vomiting, diarrhea, defecation desire, salivation^[Ref]

Genitourinary

Frequency not reported: Urinary retention, urinary bladder stimulation with spontaneous voiding, elevated BUN, albuminuria^[Ref]

Hematologic

Frequency not reported: Hemolysis, decreased hemoglobin, decreased hematocrit, decreased red blood cell count, decreased white blood cell count (in presence of pre-existing leukopenia)^[Ref]

Musculoskeletal

Frequency not reported: Muscle spasticity, muscle fasciculation, increased deep tendon reflexes, clonus, bilateral Babinski^[Ref]

Nervous system

Frequency not reported: Paresthesia, headache, dizziness, hyperactivity, involuntary movement, convulsion, decreased cerebral blood flow velocity^[Ref]

Ocular

Frequency not reported: Pupillary dilation^[Ref]

Other

Frequency not reported: Pyrexia, perineal warmth^[Ref]

Psychiatric

Frequency not reported: Apprehension, disorientation, hallucination, confusion^[Ref]

Respiratory

Frequency not reported: Dyspnea, cough, hyperventilation, tachypnea, laryngospasm, bronchospasm, hiccough, rebound hyperventilation^[Ref]